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Objectives. The present study was undertaken tofurther char- 
acterize changes in skeletal muscle morphology and histochemis- 
try in congestive heart failure and to determine the relation of 
these changes to abnormalities of systemic and local muscle 
exercise capacity. 
Background. Abnormalities of skeletal muscle appear to play a 
role in the limitation of exercise capacity in congestive heart 
failure, but information on the changes in muscle morpholology 
and biochemistry and their relation to alterations in muscle 
function is limited. 
Methods. Eighteen men with predominantly mild to moderate 
congestive heart failure (mean + SEM New York Heart Associa- 
tion functional class 2.6 _+ 0.2, ejection fraction 24 -+ 2%) and 
eight age- and gender-matched sedentary control subjects under- 
went measurements of peak systemic oxygen consumption (Vo2) 
during cycle ergometry, resistance to fatigue of the quadriceps 
femoris muscle group and biopsy of the vastus lateralis muscle. 
Results. Peak Vo 2 and resistance to fatigue were lower in the 
patients with heart failure than in control subjects (15.7 _+ 1.2 vs. 
25.1 -+ 1.5 ml/min-kg and 63 -+ 2% vs. 85 -+ 3%, respectively, both 
p < 0.001). Patients had a lower proportion of slow twitch, type I
fibers than did control subjects (36 + 3% vs. 46 -+ 5%, p = 0.048) 
and a higher proportion of fast twitch, type IIab fibers (18 _+ 3% 
vs. 7 -+ 2%, p = 0.004). Fiber cross-sectional area was smaller, and 
single-fiber succinate dehydrogenase activity, a mitochondrial 
oxidative marker, was lower in patients (both p < 0.034). Like. 
wise, the ratio of average fast twitch to slow twitch fiber cross- 
sectional area was lower in patients (0.780 + 0.06 vs. 1.05 -+ 0.08, 
p = 0.019). Peak Vo z was strongly related to integrated succinate 
dehydrogenase activity in patients (r = 0.896, p = 0.001). Peak 
Vo2, resistance to fatigue and strength also correlated signifi- 
cantly with several measures offiber size, especially of fast twitch 
fibers, in patients. None of the skeletal muscle characteristics 
examined correlated with exercise capacity in control subjects. 
Conclusions. These results indicate that congestive heart fail- 
ure is associated with changes in the characteristics of skeletal 
muscle and local as well as systemic exercise performance. There 
are fewer slow twitch fibers, smaller fast twitch fibers and lower 
succinate dehydrogenase activity. The latter finding suggests that 
mitochondrial content of muscle is reduced in heart failure and 
that impaired aerobic-oxidative capacity may play a role in the 
limitation of systemic exercise capacity. 
(J Am Coil Cardiol 1996;27:140-5) 
Systemic exercise intolerance and fatigue are common and 
troublesome symptoms in patients with heart failure, but their 
severity correlates poorly with indexes of cardiac function 
(1-3). This discordance appears to be explained in part by 
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reduced blood flow to exercising muscle (4,5), but evidence 
also suggests an important role for abnormalities of skeletal 
muscle, including atrophy (6-8), impaired function (9,10) and 
altered metabolism (11,12). 
To determine the basis for these changes, investigators 
(6,13-16) have evaluated morphologic, histologic and bio- 
chemical characteristics of skeletal muscle in patients with 
congestive heart failure; however, these studies have not 
yielded a consistent pattern of abnormalities. Muscle biopsy 
findings have also shown variable, if any, relation with mea- 
surements ofmuscle function, muscle metabolism and exercise 
capacity. These inconsistencies probably reflect he diversity of 
functional and biochemical ssessments and the heterogeneity 
of the patient and control groups studied. 
The present study was undertaken to determine whether 
the muscle morphology and histochemistry of patients with 
heart failure differs from those of age-matched sedentary 
control subjects and, if so, whether these changes are associ- 
ated with corresponding abnormalities of muscle function and 
exercise capacity. To accomplish this, biopsy specimens from 
the lateral aspect of the quadriceps femoris were analyzed for 
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fiber type composition, cross-sectional area, capillarization and 
single-fiber succinate dehydrogenase activity, a mitochondrial 
marker. These measurements were then related to quantitative 
indexes of quadriceps femoris function and systemic exercise 
capacity. 
Methods 
Patients. Eighteen men with a history of stable, chronic 
congestive heart failure of >-6 months' duration were recruited 
from the Department of Veterans Affairs Medical Center in 
San Francisco. The diagnosis was based on a history of dyspnea 
on exertion, fatigue or fluid retention, with confirmation ofleft 
ventricular dysfunction by a radionuclide ejection fraction of 
<40% (mean : SEM 24 _+ 2%). Symptoms were classified as 
New York Heart Association functional class I, II, III and IV 
in two, seven, seven and two patients, respectively. Ten pa- 
tients had ischemic ardiomyopathy, and eight were thought to 
have primary myocardial disease. Patients were excluded if 
they had had a myocardial infarction within 6 months or if 
exercise was limited by symptoms other than fatigue or dys- 
pnea. Other criteria for exclusion included alcohol abuse 
within the previous 12 months; initiation of therapy with an 
angiotensin-converting enzyme inhibitor, long-acting nitrate, 
diuretic drug, or digitalis within 3 months; the presence of 
hemodynamically significant valvular disease; angina pectoris; 
or exercise limitation by pulmonary, peripheral vascular, ar- 
thritic or neurologic disease. 
For comparison, eight age-matched sedentary men were 
recruited from employees or patients followed up in the 
Dermatology Clinic at the Veterans Affairs Medical Center. 
These subjects had no history of heart disease and no cardiac, 
peripheral vascular or musculoskeletal abnormalities on phys- 
ical examination. To avoid the comparison of patients with 
highly fit control subjects, these subjects were excluded if their 
peak systemic oxygen consumption (Vo2) was >1 SD above 
the mean for their age. The protocol was approved by the 
Committee on Human Research at the University of Califor- 
nia, San Francisco; written informed consent was obtained 
from all participants. 
Physiologic measurements. Systemic exercise capacity. 
Peak systemic Vo 2 was quantified uring cycle ergometry 
according to our previously published techniques (8,10). 
Briefly, after esting on the cycle for 5 rain, subjects performed 
unloaded exercise for 2 rain. Subsequently, the load was 
increased to 200 kg-m/min for 2 rain, and then by 100 kg-m/min 
every 2 rain until exhaustion, as defined by the inability to 
maintain a pedal frequency of >40 rpm. Standard verbal 
encouragement was used for all subjects. 
Respiratory gas exchange was monitored by utilizing a 
metabolic art (Sensormedics, Inc.), with measurements of 
Vo 2 and carbon dioxide production (Vco2) at 15-s intervals 
throughout exercise. Peak systemic Vo2, defined as the highest 
Vo 2 achieved, was utilized to quantify exercise capacity, and 
the respiratory exchange ratio (VoJVco2) was utilized as an 
index of the adequacy of exercise. The respiratory exchange 
ratio exceeded 1.0 in all patients and control subjects. 
Knee extensor function. Knee extensor endurance and 
strength were measured with an isokinetic dynamometer (Cy- 
bex 340), as described in detail previously (8,10). Briefly, 15 
maximal knee extensions were performed at 90% in rapid 
succession over a period of -30 s. Verbal encouragement was 
given in a standardized manner throughout the procedure. 
Endurance, or the ability to withstand fatigue, was defined as 
the ratio of the mean peak torque in the last three extensions 
to the mean peak torque in the first three extensions multiplied 
times 100. The mean peak torque for the first three extensions 
was also used as a measure of strength of the quadriceps 
femoris muscle group. 
Muscle biopsies. Two biopsy specimens were taken from 
two different sites, 16 to 19 cm above the patella, by using the 
percutaneous needle technique of Bergstrom (17). Specimens 
were processed for histochemical nalysis as described in detail 
elsewhere (18-21). Briefly, sections were assayed for determi- 
nation of muscle fiber type (I, IIa, Ilab, IIb and IIc) (22), 
capillarity and succinate dehydrogenase ctivity, an estimate of 
mitochondrial content. 
Area and capillarity of the different fiber types were as- 
sessed by using a semiautomated image analysis ystem and 
Image software (National Institutes of Health). From these 
data, fiber type percent, the ratio of fast twitch to slow twitch 
fiber cross-sectional rea, fiber type-specific absolute and 
relative areas, average fiber area and the number of capillaries 
surrounding a given fiber were calculated. Regions of a section 
were excluded from analysis if they contained oblique or 
histologically abnormal fibers. At least 150 fibers in each 
section were assessed for area, capillarity and type. Data from 
the two biopsy sites in each subject were averaged to enhance 
validity of the results (23). Type IIc fibers were rare, compris- 
ing 2 < 2% overall, and were subsequently excluded from 
analyses. 
Single-fiber succinate dehydrogenase activity was deter- 
mined by using a quantitative histochemical technique de- 
scribed by Blanco et al. (24), as done previously (21). Fiber 
type-specific activity was determined by matching fibers as- 
sayed for succinate dehydrogenase with those in serial sections 
assayed for myofibrillar adenosine triphosphatase activity. 
About 60 fibers/section were thus assayed. Enzyme activities 
for type IIab and type IIb fibers were averaged and reported as 
activity for type IIb fibers, because of the low proportion of 
type IIab fibers in the control subjects. An adequate number of 
matched fibers was available for performing this fiber-specific 
analysis in 11 of 18 patients and 7 of 8 control subjects. These 
data were used with fiber type percent and average fiber 
cross-sectional rea to calculate average integrated succinate 
dehydrogenase activity irrespective of fiber type, an overall 
estimate of mitochondrial content. 
Statistical analyses. Comparisons between groups were 
made by using an independent analyses of variance with 
repeated measures over a given variable or by an independent 
t test with SuperANOVA software. Percent and ratio data 
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Table 1. Clinical Data and Physiologic Measurements in 26 Men (18 patients with congestive heart 
failure and 8 control subjects) 
Peak Vo 2 Fatigue Index Strength 
Age (yr) NYHA Class EF (%) (ml/kg-min) (%) (Nm) 
Patients 64 + 2 2.6 + 0.2 24 _+ 2 15.7 _+ 1.2" 63 + 2* 87 _+ 8 
Control subjects 65 -+ 3 . . . . . .  25.1 -+ 1.5 85 _+ 3 89 _+ 7 
*p < 0.001, patients versus control subjects. Data are presented as mean value + SEM, EF ejection fraction; Nm 
Newton-meters; NYHA Class = New York Heart Association functional c ass; Vo 2 = oxygen consumption;... = data 
not available. 
were arc-sine or log transformed before analyses. Correlations 
between variables were assessed by using Pearson's product 
correlations. Data are presented as mean value _+ SEM. 
Resu l ts  
Systemic exercise capacity and local muscle function (Table 
1). Control subjects and patients with heart failure were 
comparable in age. The heart failure group had a mean 
ejection fraction of 24 _ 2% and functional class of 2.6 _+ 0.2. 
Although peak Vo2 in the control group was relatively low, 
consistent with the age and sedentary status of these subjects, 
it was significantly higher than that in patients with heart 
failure (25.1 _+ 1.5 vs. 15.7 _ 1.2 ml/kg-min, p < 0.001). The 
fatigue index of the knee extensors, calculated from the decline 
in peak torque during the series of 15 knee extensions, was 
lower in the patients (63 _+ 2% vs. 85 -+ 3%, p < 0.001). In 
contrast, knee extensor strength was not significantly reduced 
in the patients (87 _+ 8 vs. 89 _+ 7 Newton-meters). Systemic 
and local exercise capacity, expressed as peak Vo2 and the 
fatigue index, respectively, were correlated in both patients 
(r = 0.57, p = 0.026) and control subjects (r = 0.80, p = 0.018). 
Muscle biopsy findings (Table 2). The results of the fiber 
type analyses and morphometry are given in Table 2. Signifi- 
cant intergroup differences were found in fiber type distribu- 
tion. The percent of type I fibers was less in the patients with 
heart failure than in the control subjects (36 _+ 3% vs. 46 + 
5%, p = 0.048), whereas the percent of type I lab fibers was 
greater in the patients (18 + 3% vs. 7 _+ 2%, p = 0.004). 
In both patients and control subjects, type I and IIa fibers 
were larger than l ib fibers. Overall fiber cross-sectional rea 
was smaller in patients than in control subjects, reflecting the 
smaller size of the fast twitch fibers, because the area of type I 
fibers was similar in the two groups. Therefore, the ratio of 
average fast twitch to slow twitch fiber area was lower in 
patients than in control subjects (0.78 + 0.06 vs. 1.05 -+ 0.08, 
p = 0.019). 
The hierarchy of succinate dehydrogenase activity reflected 
the usual type I > type IIa > type l ib pattern in both groups, 
but the mean activity per fiber was reduced in the patients 
(100 z 5 vs. 119 +_ 9 optical density U/min x 10 -4, p = 0.026), 
reflecting lower values in all fiber types. The number of 
capillaries around a given fiber followed the hierarchy of type 
I or type IIa > type l lab or type IIb. However, the number of 
capillaries per fiber did not differ between groups for any type 
of fiber. 
Relation of exercise capacity to muscle characteristics. 
The finding that the patients with heart failure and control 
subjects differed in both distribution and size of fiber types 
necessitated that skeletal muscle characteristics be weighted 
Table 2. Skeletal Muscle Morphology and Histochemical Findings in the 26 Study Subjects 
Fiber Type 
I IIa llab lib 
Distribution (%)*t 
Patients (n = 18) 36 _+ 3:~ 25 + 4 18 _+ 3* 22 _+ 4 
Control subjects (n = 8) 46 -+ 5 28 -+ 5 7 -+ 2 17 -- 4 
Mean cross-sectional area (/,mZ)§t 
Patients 6,031 _+ 615 5,598 _+ 647 4.792 + 644 3,413 +_ 409 
Control subjects 5,874 _+ 487 7,200 _+ 1,001 5,986 _+ 971 5,309 _+ 867 
Succinic dehydrogenase ctivity§t 
(optical density U/min × 10 4) 
Patients 130 _+ 7 94 _+ 8 II 76 _+ 8 
Control subjects 143 _+ 13 123 _+ 12 II 91 _+ 14 
Capillaries per fibert 
Patients 4.2 + 0.2 3.7 _+ 0.2 3.3 _+ 0.3 2.9 + 0.2 
Control subjects 4.2 _+ 0.2 4.1 + 0.3 3.4 _+ 0.4 3.2 _+ 0.3 
*Fiber type by group interaction by analysis of variance (ANOVA), p = 0.022; tfiber type by ANOVA, p < 0.043; 
Sp < 0.05, patients versus control subjects; §group effect by ANOVA, patients versus control subjects, p -< 0.034; Ilsuecinic 
dehydrogenase ctivity not given for Ilab fibers because of small numbers. Data are presented as mean value z SEM. 
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Figure 1. Plot shows a strong relation between i tegrated succinate 
dehydrogenase (SDH) activity and peak oxygen consumption (VO2) in 
the patients with congestive h art failure (r = 0.90, p < 0.001). od = 
optical density. 
for these variables when making comparisons between biopsy 
findings and exercise capacity. For example, the lower percent 
of type I fibers in patients was partially offset by the finding that 
their slow twitch fibers were relatively larger than their fast 
twitch counterparts a compared with observations in control 
subjects. 
In the heart failure group, peak Vo 2 correlated with 
average fiber area (r = 0.67, p = 0.007), primarily reflecting 
the close correlation with fast twitch fiber area (r = 0.68, p = 
0.006). As shown in Figure 1, the relation between peak Vo2 
and integrated succinate dehydrogenase activity was very close 
(r = 0.90, p < 0.001). Peak Vo2 did not correlate with any 
measures of fiber size in the control subjects (r values all 
<0.50, p values all >0.20), nor did it correlate with succinate 
dehydrogenase activity in this uniformly sedentary older pa- 
tient group (r = 0.28, p = 0.639). 
The knee extensor fatigue index correlated significantly 
with average fast twitch fiber area and the ratio of the fast 
twitch to slow twitch fiber area in the patients with heart failure 
(r = 0.57, p = 0.043 and r = 0.56, p = 0.037, respectively). The 
relation between the fatigue index and succinate dehydroge- 
nase activity was of borderline significance (r = 0.53, p = 
0.082). The fatigue index did not correlate with any quantita- 
tive muscle biopsy measurement i  the control group. Knee 
extensor strength was correlated to average fiber area (r = 
0.54, p = 0.046) and the average fast twitch fiber area (r = 0.57, 
p = 0.043) in patients but to none of these variables in the 
control group. 
Discuss ion  
Major findings of the present study. Several findings in this 
study provide additional insight into the pathophysiology of
skeletal muscle dysfunction and exercise intolerance in pa- 
tients with heart failure. First, they build on previous reports 
that have demonstrated a ecreased proportion of slow twitch 
oxidative fibers and reduced aerobic-oxidative enzyme content 
in such patients (6,13-16). In addition to these findings, our 
results show that the lower mitochondrial content is not 
specific to fiber type but is evident for each of the major fiber 
types of human skeletal muscle, as reflected by single-fiber 
succinate dehydrogenase activity. Second, the strong relation 
between average integrated succinate dehydrogenase activity, 
a cumulative index of mitochondrial erobic-oxidative enzyme 
content, and peak Vo2 in patients with heart failure, but not in 
control subjects, suggests that the impairment of aerobic- 
oxidative capacity may be physiologically significant and con- 
tribute to exercise limitation. Finally, several of our findings in 
patients with heart failure differ from the characteristic re- 
sponses to muscle disuse in healthy sedentary individuals 
(20,25-28). 
Skeletal muscle characteristics in heart failure. Several 
groups have reported a lower aerobic-oxidative enzyme con- 
tent in homogenates of skeletal muscle from patients with 
heart failure, irrespective of the indexes measured (6,13-16). 
In contrast, this study quantified succinate dehydrogenase 
activity in single-muscle fibers in relation to their contractile 
material. This technique affords the opportunity odetermine 
mitochondrial content in the three major fiber types of human 
skeletal muscle and eliminates the potential for extraneous 
factors, such as extracellular fluid accumulation or fatty infil- 
tration, to affect measures of enzyme activity. As is the case in 
normal subjects (21,29), aerobic-oxidative enzyme activity in 
the patients with heart failure showed a hierarchy among fiber 
types, with type I > type IIa > type lib, However, irrespective 
of fiber type, the succinate dehydrogenase activity of patients 
was lower than that in control subjects. Thus, the reduction in 
oxidative enzyme activity was not specific to one group of 
fibers. 
The results of this study also extend previous observations 
concerning differences in fiber type composition between 
patients with heart failure and control subjects. The previously 
reported finding (14,15) that such patients have a lower 
proportion of type I, slow twitch fibers and more type 2b, fast 
twitch glycolytic fibers than do normal subjects was also 
evident in this study. In addition, we subclassified fast twitch 
fibers into three types, because it is now evident that fibers that 
stain intermediate between types IIa and lib, and are thus 
distinct from their counterparts (22). Our results suggest that 
the higher proportion of type lib fibers reported previously in 
patients with heart failure may have been due to a higher 
proportion of type IIab fibers. These findings uggest transition 
to skeletal muscle with a lower aerobic-oxidative enzyme 
content because type IIab or type IIb fibers have lower 
succinate dehydrogenase activity than do type I or type IIa 
fibers (21). The mechanisms responsible for the different fiber 
type composition of skeletal muscle between patients and 
age-matched sedentary control subjects is not known, but 
preferential loss of type I fibers through denervation or 
transformation from slow to fast fibers, as may occur with 
muscle disuse, may be responsible (30,31). 
The majority of previous tudies (6,13-16) have reported at 
least a trend toward smaller type II fibers in patients with heart 
failure than in control subjects. We found that, irrespective of 
fiber type, fibers were significantly smaller in patients than in 
control subjects; in addition, the lower ratio for the cross- 
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sectional area of fast to slow fibers in patients indicates that 
atrophy is relatively specific to fast fibers. Findings concerning 
skeletal muscle capillarization in patients with heart failure 
have been variable (13-15). We found no difference between 
groups in the number of capillaries surrounding a given fiber 
type, but the maintenance of a normal capillary density is of 
interest because a reduction in proportion to the decrease in 
mitochondrial content is more typical in normal subjects. 
Functional and metabolic orrelates of the muscle biopsy 
findings. Data relating histologic characteristics of skeletal 
muscle to exercise capacity are limited and conflicting. Mancini 
et al. (13) reported that peak Vo2 and type I fiber percent were 
positively correlated, whereas peak Vo 2 and type lib fiber 
percent were inversely related. Lipkin et al. (6) did not find any 
significant correlations between knee extensor strength and 
several skeletal muscle characteristics despite abnormalities in
both. We found that peak Vo 2 correlated with average fast 
twitch fiber and overall fiber cross-sectional rea in patients 
with heart failure, as did the fatigue index and strength of the 
knee extensors. No such correlations were found in the control 
subjects. Whether these findings have mechanistic signifi- 
cance or represent associations with other factors remains 
uncertain. 
Data relating exercise performance or metabolism to the 
content of oxidative enzymes also have shown mixed results. 
We found a strong correlation between peak Vo 2 and inte- 
grated succinate dehydrogenase activity in patients with heart 
failure (r = 0.90, p < 0.001), but not in control subjects. 
Although Mancini et al. (13) did not observe a relation 
between these variables, or between aerobic-oxidative enzyme 
content and phosphorus-31 magnetic resonance spectroscopy 
indexes of metabolism, in rats with experimental heart failure, 
citrate synthase activity and phosphocreatine content during 
repetitive stimulation of the gastrocnemius muscle were signif- 
icantly correlated (32). Drexler et al. (15) and Munzel et al. 
(33) have reported a significant relation between skeletal 
muscle mitochondrial content and leg oxygen extraction, and 
parallel increases in these measures during chronic angiotensin- 
converting enzyme inhibitor therapy. 
Thus, our data, in conjunction with previous findings dem- 
onstrating that in some patients blood flow to exercising 
muscle does not limit oxygen uptake, are consistent with the 
hypothesis that the low mitochondrial content of skeletal 
muscle in heart failure influences exercise capacity (34,35). 
This is especially noteworthy for systemic exercise perfor- 
mance, which in healthy subjects is determined primarily by 
cardiac reserve (36). However, other factors are also likely to 
be involved in local muscular exercise intolerance in the 
patients. We found a 40% decrease in force during 30 s of 
repetitive knee extensions in this and a previous tudy (10). 
Patients with heart failure have also shown (37,38) a similar 
decline in force during isometric ankle flexion or knee exten- 
sion. Fatigue was rapid and severe whether intermittent blood 
flow was allowed during knee extensions or blood flow was 
occluded (10), suggesting that during these local muscle pro- 
tocols, nonmetabolic factors may also play a role. Such factors 
may include failure of excitation-contraction coupling (39), 
inefficiency of chemical to mechanical energy transduction (40) 
or reflex inhibition of motor unit activation, alone or in 
combination. 
Exercise intolerance in congestive heart failure and muscle 
disuse. Since skeletal muscle abnormalities have been recog- 
nized in heart failure, a major issue has been whether they 
occur solely as a secondary consequence of the diminished 
activity accompanying this condition or whether they are a 
direct consequence of the syndrome and an additional factor in 
propagating exercise intolerance (41). Several findings in this 
study provide circumstantial evidence that a process in addi- 
tion to muscle disuse is being expressed. First, reduced 
strength and muscle atrophy are the characteristic responses to 
inactivity (28), with disuse consistently evoking reater elative 
decreases in strength than in muscle size (20,25,27,28). In 
contrast, patients with mild to moderate heart failure exhibit 
significant atrophy but relatively well preserved strength 
(8,10, present study). Second, as discussed previously, pa- 
tients experience rapid and extreme local muscular fatigue 
(10, present study). In normal subjects, forced inactivity that 
reduces mitochondrial content by 15% to 20%, the differ- 
ence noted between patients and control subjects in this 
study, evokes only a slight decline (-6%) in the ability to 
withstand fatigue (27). Third, patients with heart failure 
showed a markedly lower ratio of fast twitch to slow twitch 
fiber size than did control subjects in this study, suggesting 
atrophy mainly of fast twitch fibers, as other investigators 
(6,13-16) have noted. In contrast, this ratio is not altered by 
muscle disuse in healthy subjects, who exhibit comparable 
atrophy of all fiber types (20,25,26). Although no definitive 
conclusions can be drawn from these observations, these 
findings suggest that as yet undefined factors are responsible 
for some of the changes in muscle function and protein 
expression in heart failure. 
Implications of this study. The results of this study provide 
additional insight into previous demonstrations of abnormal 
skeletal muscle function, metabolism and composition in pa- 
tients with congestive heart failure. They support he concept 
that reduced aerobic-oxidative capacity and possibly other 
factors contributing to extreme local muscular fatigue play a 
role in their exercise intolerance. Although it is not possible to 
conclude from the present results that these changes are 
specific for the syndrome of heart failure or to define the role 
of muscle disuse in their genesis, at least some of the abnor- 
malities appear not to be characteristic of inactivity alone. 
Additional studies are required to differentiate the contribu- 
tions of heart failure from those of chronic illness and inactivity 
in the pathophysiology of skeletal muscle dysfunction in this 
syndrome. 
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